<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-13T16:29:28Z</responseDate>
  <request identifier="oai:figshare.com:article/34044498" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34044498</identifier>
        <datestamp>2026-10-01T11:18:36Z</datestamp>
        <setSpec>category_1</setSpec>
        <setSpec>category_4</setSpec>
        <setSpec>category_7</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_19</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_61</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>portal_63</setSpec>
        <setSpec>item_type_6</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Acoustochromatography
Based on Low-Cost Polymer Columns
Enables Rapid Extracellular Vesicle Proteome Analysis from 1 μL
of Blood Plasma</dc:title>
          <dc:creator>Michael
S. Gerlt (20873362)</dc:creator>
          <dc:creator>Melinda Rezeli (647893)</dc:creator>
          <dc:creator>Thomas Laurell (72950)</dc:creator>
          <dc:subject>Biophysics</dc:subject>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Pharmacology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Developmental Biology</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>absolute residual concentration</dc:subject>
          <dc:subject>ev isolation methods</dc:subject>
          <dc:subject>enables ev enrichment</dc:subject>
          <dc:subject>early disease detection</dc:subject>
          <dc:subject>based acoustochromatography device</dc:subject>
          <dc:subject>acoustochromatography based</dc:subject>
          <dc:subject>standard methods</dc:subject>
          <dc:subject>acoustofluidic enrichment</dc:subject>
          <dc:subject>volume samples</dc:subject>
          <dc:subject>values reported</dc:subject>
          <dc:subject>poorly compatible</dc:subject>
          <dc:subject>plasma background</dc:subject>
          <dc:subject>novel ultrasound</dc:subject>
          <dc:subject>neat plasma</dc:subject>
          <dc:subject>hold promise</dc:subject>
          <dc:subject>current gold</dc:subject>
          <dc:subject>conventional approaches</dc:subject>
          <dc:subject>clinical workflows</dc:subject>
          <dc:subject>associated proteins</dc:subject>
          <dc:subject>100 ng</dc:subject>
          <dc:subject>1 μl</dc:subject>
          <dc:description>Extracellular vesicles
(EVs) hold promise as biomarkers for early
disease detection, yet their nanoscale size and the protein-rich plasma
background make enrichment essential. Conventional approaches such
as ultracentrifugation and size-exclusion chromatography require ≥100
μL of input, hours of processing, and are poorly compatible
with clinical workflows. We present a low-cost polymer-based acoustochromatography
device that enables EV enrichment from 1 μL of blood plasma
within 2–10 minsignificantly faster than current gold-standard
methods. A novel ultrasound-driven release mode increased recovery
significantly compared to the previously reported acoustofluidic chromatography
method. Comprehensive proteomic analysis confirmed highly pure EV
fractions after acoustofluidic enrichment. Apolipoproteins were depleted
to below 100 ng/mL, corresponding to &gt;99.6% depletion as compared
to neat plasma. This absolute residual concentration is lower than
values reported for other EV isolation methods and enabled the detection
of an additional 689 mostly EV-associated proteins above the plasma
background. This low-cost, scalable platform unlocks proteomic profiling
of ultralow-volume samples, paving the way for rapid and clinically
compatible EV biomarker diagnostics.</dc:description>
          <dc:date>2026-10-01T00:00:00Z</dc:date>
          <dc:type>Text</dc:type>
          <dc:type>Journal contribution</dc:type>
          <dc:identifier>10.1021/acs.analchem.6c03940.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/journal_contribution/Acoustochromatography_Based_on_Low-Cost_Polymer_Columns_Enables_Rapid_Extracellular_Vesicle_Proteome_Analysis_from_1_L_of_Blood_Plasma/34044498</dc:relation>
          <dc:rights>CC BY-NC 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
